Dr Sonal Gupta
Dr Sonal Gupta is Chief Medical Officer at CoRegen, with 20 years of experience in oncology, rare diseases, gene therapy and clinical development. She was previously Senior Vice President and Head of Clinical Development at AffyImmune and has held leadership roles at AVROBIO, CRISPR, Rubius and Selecta. She has published widely in peer-reviewed journals.
Contact info
- Website:
- https://www.coregen.com/
ArticleTargeting SRC-3 to reprogramme regulatory T cells in cancer
Could targeting SRC-3 in regulatory T cells help overcome tumour immunosuppression? Researchers explain how this approach could restore anti-tumour immunity and what remains to be proven in patients.